Virtual reality and artificial intelligence technology developer Jolly Good is likely feeling very jolly indeed after being tapped by Otsuka Pharmaceutical to develop a mental health treatment program combining pharmacological and psychotherapeutic techniques.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Jolly Good Newly Establishes CBT VR Specialist Department with Clinical Psychiatrists
April 1, 2021 GMT
TOKYO, April 1, 2021 /PRNewswire/ Leading Japanese medical VR company Jolly Good Inc. has recently established a specialized DTx Division to develop digital therapeutics (hereinafter “DTx”) using VR and AI technologies.
Dr. Ayako Kanie and Dr. Aiichiro Nakajima, psychiatrists and leaders in the development of cognitive behavioral therapy at top research institutes in Japan, will officially participate in Jolly Good. The company has been developing social skill-training VR for developmental disabilities and digital therapeutics VR for depression. After agreeing that Jolly Good’s high-quality VR could be effective for mental illnesses, both doctors made the decision to participate.